RPS Wales Palliative and End of Life Care Policy
19th December 2018
The Royal Pharmaceutical Society (RPS) in Wales, has published a policy document on pharmacy’s contribution to improved patient care for people living with life-limiting conditions. The policy focuses on making sure patients can access the full range of pharmacy expertise, maximising safe and appropriate medicines care as part of multidisciplinary care models and it aligns with the Welsh Government and NHS Wales’s Palliative and End of Life Care Delivery Plan, published in March 2017.
Recent news
- RPS Wales Palliative and End of Life Care Policy
- NICE guidelines for COPD updated
- AWMSG approves tiotropium
- Palliative Care Formulary migration to MedicinesComplete - January 2019
- Supplementary information on cannabis-based products for medicinal use
- Report on action taken on ambulatory syringe drivers
- NICE consultation on cannabis-based products for medicinal use
- Guidance and information on prescribing and supply of cannabis-based products for medicinal use
- Instanyl (fentanyl) multidose nasal sprays discontinued
- Gabapentin and pregabalin to be controlled as class C drugs
News archive
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000